Indian Phosphate share price made a stellar stock market debut on Tuesday led by heavy demand for its shares in the initial public offering (IPO). Indian Phosphate shares were listed at ₹188.10 ...

So the recent news that a new bone-strengthening drug called abaloparatide will soon be available on the NHS was music to my ears. Particularly as I have just learnt, following a DEXA bone-density ...

Indian Phosphate IPO: The initial public offering (IPO) of Indian Phosphate Ltd has been opened for public subscription on Monday, August 26. The price band of the SME IPO was fixed at Rs 94-99 per ...

Monday's appointments follow the sudden exits of leading figures, many after accusations of wrongdoing as the Communist-run country stepped up its anti-graft drive over the last two years ...

Still, the feasibility of ovarian tissue cryopreservation (OTC) following graft failure (GF) of HSCT remains unknown. In this study, we report the first case of OTC following a GF of allogenic HSCT ...

MANILA, Philippines — Pasig Mayor Vico Sotto has been charged with a second graft complaint in the Office of the Ombudsman, this time accusing him of not distributing a one-time cash allowance ...

Indian Phosphate IPO: The initial public offering (IPO) of speciality chemicals producer Indian Phosphate will open for subscription on Monday, August 26, with a price band set at ₹94 - 99 per ...

The global orthobiologics company plans to launch its SIGNAFUSE Bioactive Bone Graft in a new strip format in the next few months. The product consists of 55 percent bioglass by weigh and its mineral ...